Federated Hermes
AYTU icon

Federated Hermes’s AYTU BioPharma AYTU Stock Holding History

Federated Hermes’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-177
Closed -$283 – 2100
2023
Q2 		$283 Hold
177
– – ﹤0.01% 2072
2023
Q1 		$396 Sell
177
-51
-22% -$149 ﹤0.01% 2085
2022
Q4 		$860 Sell
228
-61
-21% -$230 ﹤0.01% 2061
2022
Q3 		$1K Sell
289
-47
-14% -$357 ﹤0.01% 2009
2022
Q2 		$5K Buy
336
+54
+19% +$691 ﹤0.01% 1892
2022
Q1 		$6K Buy
282
+122
+76% +$3.03K ﹤0.01% 1931
2021
Q4 		$4K Buy
160
+127
+385% +$5.49K ﹤0.01% 2005
2021
Q3 		$2K Buy
+33
New +$2.48K ﹤0.01% 2088

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Federated Hermes's AYTU Position: Q3 2023 in Review

Federated Hermes sold out of AYTU BioPharma (AYTU) in Q3 2023, closing a stake of 177 shares — an estimated $283 sold.

Federated Hermes first reported a position in AYTU in Q3 2021 and held it in 8 quarters. The position peaked at $6K in Q1 2022. 22 funds tracked by Wall St. Rank hold AYTU as of Q3 2023.

  • Federated Hermes reported no remaining AYTU BioPharma position as of Q3 2023 after selling out during the quarter.
  • Federated Hermes sold 177 AYTU BioPharma shares in Q3 2023, an estimated $283.
  • Federated Hermes first reported a position in AYTU BioPharma in Q3 2021 and held it in 8 quarters.
  • Federated Hermes's AYTU BioPharma position peaked at $6K in Q1 2022.
  • 22 funds tracked by Wall St. Rank held AYTU BioPharma as of Q3 2023.

Based on Federated Hermes's 13F filing for Q3 2023, filed 13 Nov 2023.